GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, GSK3B, IDO1, IGF1R, MMP2, MMP9, PPARA, PTGS2, RORC, SRC |
9.35458 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TBXAS1, TERT, TOP2A, XDH |
9.16774 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APEX1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, KIT, MMP2, PPARA, PTGS2, RORC, SRC |
9.1524 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FUT7, GLO1, IDO1, PIM1, PPARA, PTGS2, TBXAS1, XDH |
8.83506 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APEX1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, KIT, MMP2, MMP9, PPARA, PTGS2, RORC, SRC, TERT |
8.75366 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, KIT, MMP9, PTGS2, SRC, TERT |
8.59201 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTGS2, SRC, TERT, TOP2A, XDH |
8.47554 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FUT7, HSD17B1, KIT, MET, PPARA, PTGS2, TBXAS1 |
8.2963 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTGS2, SRC, TERT, TOP2A, XDH |
8.2781 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9, DHFR |
8.02175 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, APP, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GSK3B, IGF1R, KIT, MMP2, PPARA, PTGS2, SRC |
7.99672 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP2, PIM1, PPARA, PTGS2, RORC, SRC, TBXAS1, TERT, TOP2A, XDH |
7.99672 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.46162 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, PTGS2, SRC, TERT |
7.33352 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
7.24492 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
7.17689 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FLT3, PTGS2, RORC, SRC |
7.17689 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APEX1, APP, AURKB, AXL, CA2, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, GSK3B, KDR, KIT, MET, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A |
7.06379 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTGS2, SRC, TERT |
7.05018 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, CSNK2A1, CYP1B1, ESR1, ESRRA, FABP3, FLT3, IDO1, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PTGS2, SRC, TERT, XDH |
7.00655 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
6.94082 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, APP, AXL, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GSK3B, IGF1R, KDR, KIT, MMP2, MMP9, PTGS2, RORC, SRC, TERT |
6.94082 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GSK3B, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, SRC, TERT, TOP2A, XDH |
6.85222 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, KIT, PPARA, PTGS2, SRC |
6.84442 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, IDO1, PTGS2, RORC, SRC |
6.31896 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP4, FLT3, GSK3B, IGF1R, KDR, KIT, MMP2, MMP9, PTGS2, RORC, SRC, TERT, TOP2A |
6.17368 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, HSD17B1, IDO1, PTGS2, TBXAS1, XDH |
6.00793 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, APP, AXL, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GSK3B, IGF1R, KDR, KIT, MMP2, PTGS2, RORC, SRC |
5.86953 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
5.84014 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TBXAS1, TERT, TOP2A, XDH |
5.80599 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, PIM1, SRC |
5.7638 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GSK3B, KDR, KIT, MET, MMP12, MMP9, PTGS2, SRC, TERT, XDH |
5.48904 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GSK3B, IDO1, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
5.48904 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GLO1, GSK3B, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, SRC, TERT |
5.48904 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DHFR, ESR1, FABP3, FABP4, FLT3, GSK3B, HSD17B1, KDR, KIT, MET, PPARA, PTGS2, SRC, TERT, XDH |
5.48904 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GSK3B, KDR, KIT, MET, MMP12, MMP9, PTGS2, SRC, TERT, XDH |
5.48904 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APEX1, APP, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PPARA, PTGS2, RORC, SRC, TERT, TOP2A |
5.24832 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
5.15747 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TBXAS1, TERT, TOP2A, XDH |
5.08482 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HSD17B1 |
5.02706 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.98987 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, KIT, MET, PPARA, PTGS2, TBXAS1 |
4.86201 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.85472 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, APP, CYP1A1, CYP1B1, ESR1, FLT3, PTGS2, RORC, SRC |
4.8524 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.60867 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, ESRRB, FLT3, GSK3B, KDR, KIT, MMP9, PIM1, PPARA, PTGS2, RORC, SRC |
4.57221 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, ESR1, GSK3B, KIT, PPARA, RORC, SRC, TOP2A |
4.55751 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SRC, TERT |
4.51811 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.48128 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.46951 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CYP1B1, ESR1, GSK3B, IGF1R, MMP2, MMP9, PTGS2, RORC, SRC |
4.46691 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, ESRRA, FABP4, FLT3, GSK3B, IDO1, KDR, KIT, MET, MMP12, MMP2, MMP9, PTGS2, SRC, TERT, XDH |
4.36496 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, FABP4, KIT, MMP9, PTGS2, TERT |
4.18295 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, DHFR, ESR1, FABP4, GSK3B, IDO1, IGF1R, MET, MMP12, MMP2, PPARA, PTGS2, SRC, TERT, XDH |
4.12028 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
4.08375 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1 |
4.07566 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, FABP4, IDO1, IGF1R, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SRC |
4.01246 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.96567 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
3.96567 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, FLT3, GSK3B, KDR, KIT, MET, MMP12, MMP9, PTGS2, SRC, TERT, XDH |
3.93819 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
3.93656 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, GSK3B, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, SRC |
3.92584 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, GSK3B, IGF1R, PPARA, PTGS2, SRC |
3.91436 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1 |
3.86983 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.86983 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, KDR, KIT, PPARA, SRC |
3.86558 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AURKB, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
3.86558 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP12, MMP2, MMP9, PPARA, PTGS2, SRC, TERT, XDH |
3.86558 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, KIT, PPARA, PTGS2, RORC, SRC |
3.80573 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CSNK2A1, ESR1, FLT3, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PTGS2, TERT |
3.7875 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, IDO1, PPARA, PTGS2, TBXAS1 |
3.78658 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1 |
3.75066 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PPARA, PTGS2, SRC, TERT |
3.74515 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.74515 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AXL, CYP1A1, ESR1, ESRRB, FABP4, FLT3, FUT7, GLO1, GSK3B, KDR, KIT, MET, MMP2, MMP9, PTGS2, RORC, SRC, TERT, TOP2A |
3.74515 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.70565 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PTGS2, SRC, TERT, XDH |
3.69513 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DHFR, FABP3, FLT3, GSK3B, IGF1R, MMP2, PPARA, PTGS2, SRC |
3.6912 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, PTGS2, SRC |
3.60904 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PTGS2, SRC, TERT, XDH |
3.6069 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
3.59968 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, IDO1 |
3.55371 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, IDO1, KIT, MMP2, MMP9, PPARA, PTGS2, SRC, TERT, TOP2A |
3.53943 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS2, TBXAS1 |
3.51232 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
3.38164 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DHFR, FABP3, FLT3, GSK3B, IGF1R, MMP2, PPARA, PTGS2, SRC |
3.38164 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
3.37154 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
3.34944 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, ESR1, FLT3, GSK3B, IGF1R, KIT, MMP2, PTGS2, SRC |
3.34944 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.34944 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
3.32089 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, CYP19A1, CYP1A1, ESR1, ESRRB, IDO1, KIT, MMP2, MMP9, PTGS2, SRC, TOP2A |
3.26677 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, APP, AXL, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, MET, SRC, TERT |
3.25456 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, CSNK2A1, DHFR, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, PTGS2, SRC, XDH |
3.23122 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
3.22944 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GLO1, IDO1, PIM1, PPARA, PTGS2, TBXAS1 |
3.22474 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, IDO1, KIT, PTGS2 |
3.22474 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, DHFR, ESR1, FLT3, FUT7, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, SRC, TOP2A, XDH |
3.21484 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
3.12096 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
3.12096 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, CYP1B1, MMP9, PTGS2, SRC |
3.11813 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SRC, TERT |
3.11813 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, APP, AURKB, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, RORC, SRC, TERT, XDH |
3.09769 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CA9, CYP1A1, CYP1B1, DHFR, FABP3, KDR, PTGS2, SRC |
3.09769 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MMP12, PPARA, PTGS2, RORC, SRC, TERT, TOP2A |
3.09309 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, XDH |
3.06413 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.06413 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
3.05168 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.04167 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
3.02136 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, CSNK2A1, DHFR, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, PTGS2, SRC, XDH |
3.01099 |
[BP] GO:0010906 |
None
|
ESRRB, GSK3B, PPARA, RORC, SRC |
2.97392 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.96274 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SRC, TERT |
2.96223 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
2.96188 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GSK3B, IGF1R, KDR, KIT, MET, MMP12, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A |
2.96188 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.96188 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, FLT3, FUT7, GLO1, KIT, MMP9, RORC |
2.95656 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.92791 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
2.91585 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.91119 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, SRC |
2.90647 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SRC, TERT |
2.90647 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GLO1, IDO1, PIM1, PPARA, PTGS2, TBXAS1 |
2.88865 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.88266 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
2.88105 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.82754 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GLO1, IDO1, PIM1, PPARA, PTGS2, TBXAS1 |
2.8244 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, PTGS2, SRC |
2.82368 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.78495 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, CYP1B1, FLT3, KDR, KIT, MET, PTGS2, SRC, XDH |
2.78288 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, PTGS2, SRC |
2.78108 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, GSK3B, IGF1R, MMP2, PTGS2, SRC |
2.7803 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, CA2, CYP1B1, ESR1, ESRRA, ESRRB, GSK3B, IDO1, KDR, KIT, MET, MMP12, MMP9, PIM1, PTGS2, SRC, TERT, XDH |
2.77115 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
2.77115 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, CA2, CYP1B1, ESRRB, IDO1, KDR, KIT, MET, MMP12, MMP9, PIM1, PTGS2, SRC, TERT |
2.77115 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, DHFR, IDO1 |
2.75415 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
2.7402 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, CYP1A1, CYP1B1, KDR, SRC |
2.7402 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GSK3B, IDO1, XDH |
2.71773 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SRC, TERT |
2.71773 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APEX1, APP, AURKB, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, RORC, SRC, TERT, XDH |
2.71405 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.70643 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, KIT, MMP2, PPARA, PTGS2, SRC, TERT |
2.69925 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, PTGS2, SRC |
2.68199 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, KIT, MMP9, TERT |
2.67894 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.67847 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MET, MMP12, PPARA, PTGS2, RORC, SRC, TERT, TOP2A |
2.67735 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APEX1, APP, AURKB, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, IGF1R, KDR, MMP12, MMP9, PPARA, PTGS2, RORC, SRC, TERT, XDH |
2.66434 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, KIT, PTGS2 |
2.65353 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, KIT, PTGS2 |
2.65353 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.62776 |
[BP] GO:0030154 |
cell differentiation
|
ALPL, AXL, CYP1A1, ESR1, FABP4, FLT3, FUT7, GLO1, GSK3B, KDR, KIT, MMP2, MMP9, PTGS2, RORC, TOP2A |
2.61699 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, PTGS2 |
2.61699 |
[BP] GO:0010675 |
None
|
ESRRB, GSK3B, PPARA, RORC, SRC |
2.61699 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.61047 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, FUT7, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
2.61047 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.61047 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.61047 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.61047 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, GSK3B, IGF1R, MMP2, PTGS2, SRC |
2.60873 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.60873 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, GSK3B, IGF1R, SRC |
2.59142 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
2.58655 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.58009 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TBXAS1, TERT, TOP2A, XDH |
2.58009 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.57647 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, SRC, TOP2A |
2.57137 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.57088 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.57088 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
2.57088 |
[BP] GO:0031326 |
regulation of cellular biosynthetic process
|
ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GSK3B, IGF1R, KIT, MET, MMP12, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A |
2.54781 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
2.54106 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DHFR, FABP3, KDR, MMP2, PTGS2, SRC |
2.52089 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.52027 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.52027 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.49593 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MET, MMP12, PPARA, RORC, SRC, TERT, TOP2A |
2.47321 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.46822 |
[BP] GO:0006091 |
generation of precursor metabolites and energy
|
AKR1B1, AOX1, CYP19A1, CYP1A2, GSK3B, IDO1, XDH |
2.41889 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.41874 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.41874 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ESR1, ESR2, GSK3B, IGF1R, MET, MMP12, MMP9, PTGS2, SRC, TERT, XDH |
2.41482 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ESR1, ESR2, GSK3B, IGF1R, MET, MMP12, MMP9, PTGS2, SRC, TERT, XDH |
2.4027 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, CYP19A1, ESR1, ESR2, GSK3B, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, SRC, TERT, XDH |
2.3973 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, ESR2, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PTGS2, SRC, TERT, XDH |
2.3973 |
[BP] GO:1901992 |
positive regulation of mitotic cell cycle phase transition
|
APEX1, APP, CYP1A1, TERT |
2.39157 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.37899 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.37899 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.37899 |
[BP] GO:0010556 |
regulation of macromolecule biosynthetic process
|
ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GSK3B, IGF1R, KDR, KIT, MET, MMP12, PIM1, PPARA, RORC, SRC, TERT, TOP2A |
2.37551 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.35616 |
[BP] GO:0010468 |
regulation of gene expression
|
ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GSK3B, KDR, KIT, MET, MMP12, PIM1, PPARA, RORC, SRC, TERT, TOP2A, XDH |
2.35569 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.33796 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, ESR1, FABP4, IDO1, KDR, MET, MMP12, PPARA, PTGS2 |
2.31253 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, ESR1, FABP4, IDO1, MMP12, MMP2, PPARA, PTGS2, SRC |
2.2972 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.2972 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.2972 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CYP19A1, GSK3B, MMP12, PTGS2, SRC, TERT |
2.27379 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, GSK3B, IDO1, SRC, XDH |
2.27379 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.26098 |
[BP] GO:0006355 |
regulation of transcription, DNA-templated
|
ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, KIT, MET, MMP12, PIM1, PPARA, RORC, SRC, TERT, TOP2A |
2.25591 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.24942 |
[BP] GO:1903506 |
regulation of nucleic acid-templated transcription
|
ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, KIT, MET, MMP12, PIM1, PPARA, RORC, SRC, TERT, TOP2A |
2.23009 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AXL, CA2, CYP1B1, ESR1, ESRRA, ESRRB, GSK3B, IDO1, KDR, KIT, PIM1, PPARA, PTGS2, RORC, SRC, TERT, XDH |
2.22924 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.22924 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.22924 |
[BP] GO:2001141 |
regulation of RNA biosynthetic process
|
ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, KIT, MET, MMP12, PIM1, PPARA, RORC, SRC, TERT, TOP2A |
2.22569 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, ESR1, FLT3, KIT, MET, PIM1, SRC |
2.19948 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.19948 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, ESR1, GSK3B, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC |
2.19807 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.19671 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, FABP4, FLT3, GSK3B, IGF1R, KIT, MET, MMP9, PIM1, PPARA, PTGS2, SRC, TERT, XDH |
2.19284 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1 |
2.19164 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC |
2.1915 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.1915 |
[BP] GO:2000112 |
regulation of cellular macromolecule biosynthetic process
|
ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GSK3B, IGF1R, KIT, MET, MMP12, PIM1, PPARA, RORC, SRC, TERT, TOP2A |
2.15858 |
[BP] GO:1901989 |
None
|
APEX1, APP, CYP1A1, TERT |
2.14637 |
[BP] GO:0051172 |
None
|
APEX1, APP, AURKB, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, FABP4, IGF1R, MMP12, MMP9, PPARA, PTGS2, RORC, SRC, TERT, XDH |
2.14012 |
[BP] GO:0051099 |
positive regulation of binding
|
APP, GSK3B, MET, MMP9, TERT |
2.14012 |
[BP] GO:0032092 |
positive regulation of protein binding
|
APP, GSK3B, MMP9, TERT |
2.13109 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, SRC |
2.12221 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.12055 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.11875 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, CYP1B1, ESR1, ESR2, KIT, PIM1 |
2.11875 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, ESR1, FABP4, IDO1, PPARA, PTGS2 |
2.11875 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC |
2.08776 |
[BP] GO:0010907 |
None
|
ESRRB, PPARA, SRC |
2.08776 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, CSNK2A1, DHFR, ESR1, FABP4, FLT3, GSK3B, IGF1R, KIT, MMP9, PTGS2, SRC, TERT, XDH |
2.06209 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.06209 |
[BP] GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, MMP9, PTGS2, SRC |
2.05459 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.05339 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, GSK3B, PPARA, RORC, SRC |
2.03132 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, KDR, KIT, PTGS2, TERT |
2.02114 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, CYP1B1, FABP3, IDO1, PTGS2, TERT, XDH |
2.00881 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AXL, CYP1A1, ESR1, KIT, PTGS2, SRC |
2.0006 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, APP, AURKB, AXL, CA1, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
2.57073 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, APP, AURKB, AXL, CA1, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
2.39009 |
[CC] GO:0043231 |
intracellular membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, APEX1, APP, AURKB, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, GSK3B, IGF1R, KDR, KIT, MMP12, MMP2, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TOP2A, XDH |
2.01759 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, APP, AURKB, CA1, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, HSD17B1, IDO1, KDR, KIT, MMP2, MMP9, PIM1, PTGS2, SRC, TBXAS1, TERT, TOP2A, XDH |
1.88248 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP |
1.84659 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, TBXAS1, XDH |
15.0521 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GSK3B, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SRC, TBXAS1, TERT, TOP2A, XDH |
14.7146 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.3883 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FLT3, FUT7, GLO1, GSK3B, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, SRC, TBXAS1, TERT, TOP2A, XDH |
10.0413 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, GLO1, IDO1, KIT, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, TBXAS1, TERT, TOP2A, XDH |
9.1524 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, GLO1, IDO1, KIT, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, TBXAS1, TERT, TOP2A, XDH |
8.72439 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.46162 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, RORC |
7.40739 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.94082 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD17B1, IDO1, PTGS2, TBXAS1, XDH |
6.26585 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.95142 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2, SRC, TBXAS1 |
5.87243 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS2, SRC, TBXAS1 |
5.66554 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.66476 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.66476 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD17B1, IDO1, PTGS2, SRC, TBXAS1, XDH |
5.49551 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, XDH |
5.24832 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.24349 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
5.12685 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.55751 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, PPARA, SRC, TOP2A |
4.51811 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1, RORC |
4.37299 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.92466 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.86983 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.79642 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.75726 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, SRC |
3.51232 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP12, PIM1, PPARA, PTGS2, RORC, SRC, TBXAS1, TERT, TOP2A, XDH |
3.38164 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, SRC |
3.34944 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, AOX1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP12, PIM1, PPARA, PTGS2, RORC, SRC, TBXAS1, TERT, TOP2A, XDH |
3.31503 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS2, TBXAS1 |
3.12096 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, CSNK2A1, ESR1, ESR2, FLT3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, TERT, TOP2A, XDH |
3.04167 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1 |
2.99024 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.98995 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.96223 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.96188 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.90647 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, SRC |
2.87064 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HSD17B1, PPARA, RORC |
2.72136 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CSNK2A1, DHFR, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP2A, XDH |
2.68897 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KDR, KIT, MET, PPARA, RORC |
2.68199 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, SRC, TERT |
2.67847 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.62974 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.61047 |
[MF] GO:0008134 |
transcription factor binding
|
APEX1, ESR1, ESRRB, FLT3, GSK3B, PIM1, PPARA, SRC, TERT |
2.47958 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B1, XDH |
2.43036 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.37899 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX5, IDO1, PTGS2 |
2.33796 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX5, IDO1, PTGS2 |
2.2972 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KDR, KIT, MET, PPARA, RORC |
2.23485 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.19948 |
[MF] GO:0043168 |
anion binding
|
AOX1, APP, AURKB, AXL, CSNK2A1, DHFR, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP2A, XDH |
2.16615 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KDR, KIT, MET, PPARA, RORC |
2.12221 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.06209 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.06209 |